XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Disposition of the Hospital Products - Unaudited Pro Forma Condensed Combined Statement of Income (Loss) (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Product sales $ 0 $ 0 $ 0 $ 22,334
Total operating expense 25,663 13,697 62,410 2,259
Operating income (loss) (25,663) (13,697) (62,410) 20,075
Cost of products 0 0 0 5,742
Research and development expenses 4,380 5,569 14,994 15,156
Selling, general and administrative expenses 21,283 8,423 47,469 23,431
Intangible asset amortization 0 0 0 406
Changes in fair value of contingent consideration 0 (69) 0 3,327
Other expense - changes in fair value of contingent consideration payable $ 0 $ 0 $ 0 435
Pro Forma        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Product sales       159
Total operating expense       (6,230)
Operating income (loss)       6,389
Total income before income taxes       (4,203)
As Reported        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Product sales       22,334
Total operating expense       2,259
Operating income (loss)       20,075
Total income before income taxes       9,048
Pro Forma Adjustments | Pro Forma        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Product sales       (22,175)
Total operating expense       (8,489)
Operating income (loss)       (13,686)
Total income before income taxes       (13,251)
Pro Forma Adjustments | Pro Forma | Disposal Group, Disposed of by Sale, Not Discontinued Operations        
Error Corrections and Prior Period Adjustments Restatement [Line Items]        
Cost of products       3,540
Research and development expenses       407
Selling, general and administrative expenses       809
Intangible asset amortization       406
Changes in fair value of contingent consideration       3,327
Other expense - changes in fair value of contingent consideration payable       $ 435